Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ACLARUBICIN vs ACORAMIDIS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ACLARUBICIN vs ACORAMIDIS: Safety Overview

Metric ACLARUBICIN ACORAMIDIS
Total FAERS Reports 314 234
Deaths Reported 60 8
Death Rate 19.1% 3.4%
Hospitalizations 73 40
Average Patient Age 51.1 yrs 79.6 yrs
% Female Patients 47.2% 18.3%
FDA Approval Date N/A Nov 22, 2024
Manufacturer N/A BridgeBio Pharma, Inc.
Route N/A ORAL
Marketing Status N/A Prescription